‡ In these countries please contact our distributor
Learn more about our participation in GS1 and UDI initiatives
More about GS1 and UDI Initiatives
Learn more about product patents applicable in the United States only.
More about Patents
We invested $292 million in Research and Development (R&D) in 2019, equivalent to 5.7% of Group revenue.
More about Research and Development
Detailed information on reimbursement guidelines, codes, payment methodologies and a reimbursement calculation tool for our surgical devices and products.
More about US Reimbursement